Hepatic and pancreatic fat as imaging biomarkers of metabolic syndrome.

CONCLUSIONS: Pancreatic steatosis can be considered a marker of metabolic syndrome and diabetes. Quantitative MRI enables the diagnosis and grading of fatty pancreas through simple chemical shift techniques. PMID: 31447050 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31447050?dopt=Abstract

Source: Radiologia - August 21, 2019 Category: Radiology Authors: Ballester-Vallés C, Flores-Méndez J, Delgado-Moraleda J, Ballesteros Martín-Portugués A, Merino-Torres JF, Fornés-Ferrer V, Martí-Bonmatí L Tags: Radiologia Source Type: research